Sadiya Abdullahi Yusuf, Kano
The Kano State Drugs and Medical Consumable Supply Agency (DMCSA) has recorded significant progress in its operations over the last three months, the agency’s Director-General, Pharmacist Gali Sule, announced.
Speaking during a review of the agency’s performance from September to December 2025, Sule said almost all outstanding debts inherited from the previous administration have been settled. “Looking at our records, this is a huge advancement since we came on board. Our current capital now stands at N532 million,” he said.
The DG highlighted that the supply of medicines to hospitals across the state has reached 97 percent. “Although the records fluctuate depending on capital availability, our target is to reach 99 percent supply in the near future,” Sule added, noting that the agency aims to ensure medicines remain affordable and accessible to all residents.
Sule also disclosed that a state-of-the-art Pharma-Grade Warehouse will soon be commissioned following approval by the Kano State Governor. The facility is expected to boost internal medicine production, with all products fully registered with the Pharmaceutical Council of Nigeria (PCN) and NAFDAC to guarantee safety and authenticity.
Read Also:
Governor Yusuf Prioritizes Kano, Dismisses 2027 Politics
DMCSA Marks Governor Yusuf’s Birthday With Medical Donation to Schools
Arewa Health Promotion Initiative Sensitises Kura Communities on Clean Water and Sanitation
On funding, Sule expressed hope that the state government would provide additional capital to further strengthen the agency’s activities, promising repayment within a year. Currently, DMCSA supplies medicines and consumables to more than 1,200 primary healthcare centres, 46 secondary hospitals, and several tertiary hospitals at regulated and affordable prices. “Drug access has increased significantly due to the strengthened Drug Revolving Fund system,” he added.
Plans are also underway to launch a Public-Private Partnership (PPP) initiative, which will allow private investors to contribute to the agency’s operations. Sule said the PPP aligns with the Federal Government’s agenda to reduce drug imports and boost local medicine production.
In addition, a Quality Control Laboratory is under construction and expected to be commissioned in 2026. The laboratory will test all medicines supplied in the state, ensuring substandard products are eliminated. “This will benefit Dangwauro Pharmaceutical Market, removing the need to send medicines to Kaduna for testing,” Sule said.
The DMCSA DG concluded by reiterating his full support for His Excellency, Alhaji Abba Kabir Yusuf, praising the governor for his dedication to transforming healthcare in Kano State. “I am fully in support of his vision to ensure Kano prospers,” he stated.